Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

被引：0
|
作者：
Paola Ponzani
Cesare Berra
Alessandra Di Lelio
Paola Del Sindaco
Chiara Di Loreto
Francesco Reggiani
Giuseppe Lucisano
Maria Chiara Rossi
机构：
[1] SSD Endocrinologia,
[2] Diabetologia e Malattie Metaboliche ASL3 Genovese,undefined
[3] Humanitas Research Institute,undefined
[4] CORESEARCH,undefined
[5] Center for Outcomes Research and Clinical Epidemiology,undefined
[6] Servizio di Diabetologia del Perugino USL Umbria 1,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Add-on; Effectiveness; Glycemic variability; Hypoglycemia; Insulin degludec; Real-world data; Switch; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2209 / 2218
页数：9
相关论文
共 50 条
  • [31] Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus
    Bipin Sethi
    Subhankar Chowdhury
    Supratik Bhattacharya
    Sagar Katare
    Sachin Suryawanshi
    Hanmant Barkate
    International Journal of Diabetes in Developing Countries, 2023, 43 : 214 - 225
  • [32] Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience
    Oner, Hatice
    Gunhan, Hatice Gizem
    Yavuz, Dilek Gogas
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2022, 3
  • [33] INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE
    Al Awadi, F.
    Aly, H.
    Bashier, A.
    Benavente, J. Medina
    Dhanwal, D. Kumar
    Jallo, M.
    Singhal, S.
    Abusnana, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [34] Insulin degludec - The impact of a new basal insulin on care in type 2 diabetes
    Khunti, Kamlesh
    Cos, Xavier
    Rutten, Guy
    PRIMARY CARE DIABETES, 2014, 8 (02) : 119 - 125
  • [35] COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC (IDEG) IN REAL-WORLD CLINICAL PRACTICE IN ITALY
    Haldrup, S.
    Lapolla, A.
    Gundgaard, J.
    Wolden, M. L.
    VALUE IN HEALTH, 2017, 20 (09) : A478 - A479
  • [36] Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes
    Luo, Sihui
    Zheng, Xueying
    Bao, Wei
    Nie, Sheng
    Ding, Yu
    Yue, Tong
    Zhou, Yilun
    Hu, Ying
    Li, Hua
    Yang, Qiongqiong
    Wan, Qijun
    Liu, Bicheng
    Xu, Hong
    Li, Guisen
    Xu, Gang
    Chen, Chunbo
    Liu, Huafeng
    Shi, Yongjun
    Zha, Yan
    Kong, Yaozhong
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Ji, Linong
    Hou, Fan Fan
    Weng, Jianping
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [37] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [38] Multidisciplinary stakeholder engagement in a type 2 diabetes comparative effectiveness study utilizing real-world data
    Golembiewski, Elizabeth H.
    Mickelson, Mindy M.
    Brito, Juan P.
    Montori, Victor M.
    Mccoy, Rozalina G.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 8 (01)
  • [39] Real-world efficacy data in patients with type 2 diabetes on Semaglutide
    Zitterl, Andreas
    Peric, Slobodan
    Pichler, Maximilian
    Prager, Margarete
    Prager, Rudolf
    Stulnig, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 265 - 265
  • [40] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study
    Nicodemus Jr, Nemencio
    Ang-Golangco, Nerissa
    Aquitania, Grace
    Ardena, Gregory Joseph Ryan
    Dampil, Oliver Allan
    Fernando, Richard Elwyn
    Flor, Nicole-Therese
    Kho, Sjoberg
    Matawaran, Bien
    Mirasol, Roberto
    Panelo, Araceli
    Pasaporte, Francis
    Puno-Rocamora, Mercerose
    Shoeb, Ahsan
    Tolentino, Marsha
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2024,
12345